Advancing diagnostics and therapy in transthyretin amyloid cardiomyopathy

Advancing diagnostics and therapy in transthyretin amyloid cardiomyopathy

Saved in:

Bibliographic Details
Main Authors:	Katarzyna Holcman, Michał Tkaczyszyn
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	ESC Heart Failure
Online Access:	https://doi.org/10.1002/ehf2.15166
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy
by: Pablo Garcia‐Pavia, et al.
Published: (2024-12-01)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
by: J Gustav Smith, et al.
Published: (2021-12-01)

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
by: Rosa Lauppe, et al.
Published: (2022-06-01)

Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy
by: Hugo R. Ramos, et al.
Published: (2024-12-01)

Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation
by: Margrethe Flesvig Holt, et al.
Published: (2025-08-01)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
by: Fumi Oike, et al.
Published: (2022-06-01)

NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)

Portuguese recommendations for the management of transthyretin amyloid cardiomyopathy (Part 1 of 2): Screening, diagnosis and treatment. Developed by the Task Force on the management of transthyretin amyloid cardiomyopathy of the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology
by: Nuno Marques, et al.
Published: (2025-02-01)

Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study
by: Giacomo Tini, et al.
Published: (2025-02-01)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty
by: Yasuhiro Izumiya, et al.
Published: (2025-04-01)

Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild‐Type Transthyretin Amyloid Cardiomyopathy
by: Bertil Ladefoged, et al.
Published: (2024-07-01)

Suspicion and referral of patients with transthyretin amyloid cardiomyopathy: Recommendations by a Portuguese multidisciplinary expert panel
by: Dulce Brito, et al.
Published: (2025-02-01)

Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
by: Katrine Bay, et al.
Published: (2022-06-01)

Transthyretin amyloid cardiomyopathy in France: A cross-sectional multi-centre study (333 patients)
by: Thibaud Damy, et al.
Published: (2024-01-01)

Incidence and Predictors of Right Ventricular Reverse Remodeling in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
by: Nicoleta Nita, et al.
Published: (2025-05-01)

Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer Therapies
by: Julien Dang, et al.
Published: (2025-06-01)

Diagnosing Smoldering Multiple Myeloma and Light Chain Amyloidosis in the Setting of Severe Transthyretin Amyloid Cardiomyopathy and Extracardiac Sarcoidosis
by: Robert A. Churchill, et al.
Published: (2024-04-01)

Uncovering cell type-specific phenotypes using a novel human in vitro model of transthyretin amyloid cardiomyopathy
by: Jiabin Qin, et al.
Published: (2025-07-01)

Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey
by: Francesco Cappelli, et al.
Published: (2025-06-01)

Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study
by: Yen-Hung Lin, et al.
Published: (2025-06-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Actual Condition of Transthyretin Amyloid Cardiac Amyloidosis: Single Centre Experience
by: Shunsuke Kiuchi, et al.
Published: (2024-07-01)

Long-term follow-up of retinal amyloid angiopathy in a large Chinese family with hereditary amyloid transthyretin
by: Jiangning Xu, et al.
Published: (2025-04-01)

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

Advances in the treatment of transthyretin amyloidosis
by: Intissar Anan
Published: (2025-07-01)

Phenotype and prognostic factors in geriatric and non‐geriatric patients with transthyretin cardiomyopathy
by: Eugenia Volpentesta, et al.
Published: (2024-12-01)

Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis
by: Bettina Heidecker, et al.
Published: (2025-03-01)

Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosis
by: Aurélien Palmyre, et al.
Published: (2025-06-01)

Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
by: M. V. Ezhikova, et al.
Published: (2024-11-01)

Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy
by: Yi-Hsin Hung, et al.
Published: (2025-04-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

Amyloid Cardiomyopathy: Review of A Fatal Case Report
by: O. V. Soldatova, et al.
Published: (2025-05-01)

Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomography/computed tomography: a single-center, cross-sectional study
by: Masakazu Tsujimoto, et al.
Published: (2025-08-01)

Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis
by: Avi Chakrabartty
Published: (2024-09-01)

Vutrisiran in Transthyretin Amyloidosis
by: Ronald M. Witteles, MD, et al.
Published: (2025-09-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01)

Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry
by: Cristhian Espinoza Romero, et al.
Published: (2025-06-01)

Echocardiographic features of amyloid cardiomyopathy phenotypes in patients with different types of amyloidosis
by: Olga Ya. Сhaikovskaya, et al.
Published: (2025-01-01)

Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis
by: Martha Grogan, et al.
Published: (2025-09-01)